BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) EBIT

Annual EBIT:

$529.80M+$335.36M(+172.48%)
December 31, 2024

Summary

  • As of today, BMRN annual earnings before interest & taxes is $529.80 million, with the most recent change of +$335.36 million (+172.48%) on December 31, 2024.
  • During the last 3 years, BMRN annual EBIT has risen by +$601.14 million (+842.66%).
  • BMRN annual EBIT is now at all-time high.

Performance

BMRN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Quarterly EBIT:

$301.51M+$70.60M(+30.57%)
June 30, 2025

Summary

  • As of today, BMRN quarterly earnings before interest & taxes is $301.51 million, with the most recent change of +$70.60 million (+30.57%) on June 30, 2025.
  • Over the past year, BMRN quarterly EBIT has increased by +$198.05 million (+191.43%).
  • BMRN quarterly EBIT is now at all-time high.

Performance

BMRN Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM EBIT:

$824.59M+$198.05M(+31.61%)
June 30, 2025

Summary

  • As of today, BMRN TTM earnings before interest & taxes is $824.59 million, with the most recent change of +$198.05 million (+31.61%) on June 30, 2025.
  • Over the past year, BMRN TTM EBIT has increased by +$565.05 million (+217.72%).
  • BMRN TTM EBIT is now at all-time high.

Performance

BMRN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BMRN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+172.5%+191.4%+217.7%
3Y3 Years+842.7%+873.5%+1396.5%
5Y5 Years+565.5%+706.1%+934.4%

BMRN EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+842.7%at high+1209.5%at high+2744.3%
5Y5-Yearat high+565.5%at high+539.5%at high+793.9%
All-TimeAll-Timeat high+264.2%at high+366.7%at high+342.2%

BMRN EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
$301.51M(+30.6%)
$824.59M(+31.6%)
Mar 2025
-
$230.91M(+67.2%)
$626.54M(+31.8%)
Dec 2024
$529.80M(+172.5%)
$138.12M(-10.3%)
$475.21M(+21.6%)
Sep 2024
-
$154.05M(+48.9%)
$390.76M(+50.6%)
Jun 2024
-
$103.46M(+30.0%)
$259.54M(+21.9%)
Mar 2024
-
$79.58M(+48.3%)
$212.85M(+9.9%)
Dec 2023
$194.44M(+1804.4%)
$53.66M(+135.1%)
$193.73M(+71.6%)
Sep 2023
-
$22.83M(-59.8%)
$112.89M(+59.8%)
Jun 2023
-
$56.77M(-6.1%)
$70.66M(+57.5%)
Mar 2023
-
$60.47M(+322.5%)
$44.85M(+337.9%)
Dec 2022
$10.21M(+114.3%)
-$27.18M(-40.0%)
$10.24M(+132.8%)
Sep 2022
-
-$19.41M(-162.7%)
-$31.18M(+51.0%)
Jun 2022
-
$30.97M(+19.8%)
-$63.60M(+15.3%)
Mar 2022
-
$25.85M(+137.7%)
-$75.11M(-0.1%)
Dec 2021
-$71.34M(+32.0%)
-$68.60M(-32.4%)
-$75.06M(-94.0%)
Sep 2021
-
-$51.82M(-366.3%)
-$38.70M(+22.0%)
Jun 2021
-
$19.46M(-24.9%)
-$49.63M(+58.2%)
Mar 2021
-
$25.90M(+180.4%)
-$118.83M(-10.3%)
Dec 2020
-$104.87M(+7.9%)
-$32.24M(+48.6%)
-$107.74M(-9.0%)
Sep 2020
-
-$62.75M(-26.1%)
-$98.83M(-184.1%)
Jun 2020
-
-$49.75M(-234.5%)
-$34.79M(+6.2%)
Mar 2020
-
$37.00M(+258.6%)
-$37.09M(+67.4%)
Dec 2019
-$113.81M(+28.3%)
-$23.32M(-1910.9%)
-$113.76M(+31.0%)
Sep 2019
-
$1.29M(+102.5%)
-$164.76M(+7.9%)
Jun 2019
-
-$52.05M(-31.2%)
-$178.93M(-8.3%)
Mar 2019
-
-$39.67M(+46.6%)
-$165.22M(-3.6%)
Dec 2018
-$158.65M(-17.4%)
-$74.32M(-476.6%)
-$159.41M(-12.5%)
Sep 2018
-
-$12.89M(+66.4%)
-$141.69M(+2.3%)
Jun 2018
-
-$38.34M(-13.2%)
-$145.01M(+1.1%)
Mar 2018
-
-$33.86M(+40.2%)
-$146.57M(-8.5%)
Dec 2017
-$135.15M(+49.5%)
-$56.60M(-249.2%)
-$135.15M(+19.7%)
Sep 2017
-
-$16.21M(+59.4%)
-$168.30M(+20.8%)
Jun 2017
-
-$39.90M(-77.8%)
-$212.44M(-6.2%)
Mar 2017
-
-$22.44M(+75.0%)
-$200.06M(+24.7%)
Dec 2016
-$267.82M(+17.0%)
-$89.76M(-48.7%)
-$265.62M(+8.1%)
Sep 2016
-
-$60.35M(-119.4%)
-$288.90M(+8.1%)
Jun 2016
-
-$27.51M(+68.7%)
-$314.33M(+7.7%)
Mar 2016
-
-$88.00M(+22.1%)
-$340.43M(-5.2%)
Dec 2015
-$322.58M(-96.0%)
-$113.03M(-31.8%)
-$323.69M(-20.1%)
Sep 2015
-
-$85.78M(-60.0%)
-$269.41M(-10.9%)
Jun 2015
-
-$53.61M(+24.8%)
-$242.87M(-18.3%)
Mar 2015
-
-$71.26M(-21.3%)
-$205.37M(-27.3%)
Dec 2014
-$164.62M(-18.8%)
-$58.76M(+0.8%)
-$161.27M(-9.1%)
Sep 2014
-
-$59.24M(-267.7%)
-$147.76M(-14.4%)
Jun 2014
-
-$16.11M(+40.7%)
-$129.21M(+5.1%)
Mar 2014
-
-$27.15M(+40.0%)
-$136.09M(+1.2%)
Dec 2013
-$138.59M(-38.8%)
-$45.25M(-11.2%)
-$137.70M(-6.9%)
Sep 2013
-
-$40.69M(-77.0%)
-$128.79M(-29.9%)
Jun 2013
-
-$23.00M(+20.1%)
-$99.18M(+10.2%)
Mar 2013
-
-$28.77M(+20.8%)
-$110.41M(-5.8%)
Dec 2012
-$99.86M(-214.7%)
-$36.34M(-227.9%)
-$104.38M(-53.4%)
Sep 2012
-
-$11.08M(+67.6%)
-$68.04M(-19.5%)
Jun 2012
-
-$34.23M(-50.6%)
-$56.96M(-147.7%)
Mar 2012
-
-$22.73M(>-9900.0%)
-$22.99M(-754.2%)
DateAnnualQuarterlyTTM
Dec 2011
-$31.73M(-666.4%)
$0.00(0.0%)
$3.52M(+2030.3%)
Sep 2011
-
$0.00(+100.0%)
$165.00K(+112.4%)
Jun 2011
-
-$262.00K(-106.9%)
-$1.33M(-24.6%)
Mar 2011
-
$3.78M(+212.7%)
-$1.07M(+78.0%)
Dec 2010
-$4.14M(-125.1%)
-$3.35M(-124.2%)
-$4.84M(-224.2%)
Sep 2010
-
-$1.49M(>-9900.0%)
-$1.49M(>-9900.0%)
Jun 2010
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2010
-
$0.00(0.0%)
$4.31M(+1597.6%)
Dec 2009
$16.49M(-58.5%)
$0.00(0.0%)
-$288.00K(-100.9%)
Sep 2009
-
$0.00(-100.0%)
$31.77M(-6.9%)
Jun 2009
-
$4.31M(+193.7%)
$34.12M(-0.6%)
Mar 2009
-
-$4.60M(-114.4%)
$34.34M(-13.6%)
Dec 2008
$39.76M(+169.4%)
$32.06M(+1263.5%)
$39.76M(+2480.5%)
Sep 2008
-
$2.35M(-48.1%)
-$1.67M(+92.2%)
Jun 2008
-
$4.53M(+453.8%)
-$21.52M(+45.7%)
Mar 2008
-
$818.00K(+108.7%)
-$39.65M(+30.8%)
Dec 2007
-$57.29M(-30.4%)
-$9.37M(+46.5%)
-$57.29M(+12.1%)
Sep 2007
-
-$17.50M(-28.7%)
-$65.15M(-14.7%)
Jun 2007
-
-$13.60M(+19.1%)
-$56.82M(-15.2%)
Mar 2007
-
-$16.82M(+2.4%)
-$49.30M(-12.2%)
Dec 2006
-$43.95M(+42.2%)
-$17.23M(-87.8%)
-$43.95M(-3.1%)
Sep 2006
-
-$9.18M(-50.9%)
-$42.61M(+14.8%)
Jun 2006
-
-$6.08M(+46.9%)
-$50.00M(+24.2%)
Mar 2006
-
-$11.46M(+27.9%)
-$65.99M(+13.2%)
Dec 2005
-$76.05M(+0.8%)
-$15.90M(+4.0%)
-$76.05M(+0.5%)
Sep 2005
-
-$16.56M(+25.0%)
-$76.45M(+8.0%)
Jun 2005
-
-$22.08M(-2.6%)
-$83.11M(-6.9%)
Mar 2005
-
-$21.52M(-32.0%)
-$77.73M(-5.3%)
Dec 2004
-$76.69M(-10.8%)
-$16.30M(+29.8%)
-$73.79M(+10.7%)
Sep 2004
-
-$23.21M(-39.0%)
-$82.60M(-3.2%)
Jun 2004
-
-$16.70M(+5.0%)
-$80.06M(-0.6%)
Mar 2004
-
-$17.58M(+30.0%)
-$79.55M(+3.6%)
Dec 2003
-$69.21M(-26.6%)
-$25.11M(-21.5%)
-$82.52M(-13.2%)
Sep 2003
-
-$20.67M(-27.7%)
-$72.91M(-8.4%)
Jun 2003
-
-$16.19M(+21.2%)
-$67.28M(-5.0%)
Mar 2003
-
-$20.54M(-32.5%)
-$64.07M(-12.6%)
Dec 2002
-$54.68M(-35.7%)
-$15.50M(-3.0%)
-$56.88M(+10.4%)
Sep 2002
-
-$15.05M(-16.0%)
-$63.49M(-9.2%)
Jun 2002
-
-$12.97M(+2.8%)
-$58.12M(-4.1%)
Mar 2002
-
-$13.35M(+39.6%)
-$55.81M(-8.3%)
Dec 2001
-$40.30M(-22.1%)
-$22.12M(-128.7%)
-$51.52M(-85.7%)
Sep 2001
-
-$9.67M(+9.3%)
-$27.74M(+2.5%)
Jun 2001
-
-$10.67M(-17.8%)
-$28.45M(-13.9%)
Mar 2001
-
-$9.06M(-645.3%)
-$24.97M(-6.5%)
Dec 2000
-$33.00M(-20.0%)
$1.66M(+116.0%)
-$23.45M(+23.7%)
Sep 2000
-
-$10.38M(-44.4%)
-$30.74M(-3.9%)
Jun 2000
-
-$7.19M(+4.7%)
-$29.60M(+0.4%)
Mar 2000
-
-$7.54M(-34.0%)
-$29.71M(-11.1%)
Dec 1999
-$27.50M(-112.3%)
-$5.63M(+39.1%)
-$26.75M(-26.6%)
Sep 1999
-
-$9.24M(-26.5%)
-$21.12M(-77.7%)
Jun 1999
-
-$7.30M(-59.3%)
-$11.89M(-159.3%)
Mar 1999
-
-$4.58M(>-9900.0%)
-$4.58M(>-9900.0%)
Dec 1998
-$12.95M(-357.9%)
-
-
Dec 1998
-
$0.00
$0.00
Dec 1997
-$2.83M
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual EBIT year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly EBIT year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM EBIT year-on-year change?

What is BioMarin Pharmaceutical Inc. annual earnings before interest & taxes?

The current annual EBIT of BMRN is $529.80M

What is the all-time high annual EBIT for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual earnings before interest & taxes is $529.80M

What is BioMarin Pharmaceutical Inc. annual EBIT year-on-year change?

Over the past year, BMRN annual earnings before interest & taxes has changed by +$335.36M (+172.48%)

What is BioMarin Pharmaceutical Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of BMRN is $301.51M

What is the all-time high quarterly EBIT for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly earnings before interest & taxes is $301.51M

What is BioMarin Pharmaceutical Inc. quarterly EBIT year-on-year change?

Over the past year, BMRN quarterly earnings before interest & taxes has changed by +$198.05M (+191.43%)

What is BioMarin Pharmaceutical Inc. TTM earnings before interest & taxes?

The current TTM EBIT of BMRN is $824.59M

What is the all-time high TTM EBIT for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM earnings before interest & taxes is $824.59M

What is BioMarin Pharmaceutical Inc. TTM EBIT year-on-year change?

Over the past year, BMRN TTM earnings before interest & taxes has changed by +$565.05M (+217.72%)
On this page